AzTrials
AzTrials

Post Intensive Care Syndrome (PICS)PICASSONCT07466446

Post Intensive Care Accelerometery to Study and Support Recovery Outcomes

An observational study of Post Intensive Care Syndrome (PICS), run by University of Edinburgh at 3 sites in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary purpose of this study is to find out whether a wrist-worn activity monitor can help healthcare professionals understand how people recover after they leave the intensive care unit (ICU), where they were cared for when they were most unwell. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post Intensive Care Syndrome (PICS)
How many people
40 participants
Where
3 sitesUnited Kingdom
Study dates
30 Mar 2026to 1 Feb 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults discharged from an intensive care unit and hospital who are at high risk of post-ICU syndrome and hospital readmission.

Who may be able to join

  • Adults aged 18 years or older
  • Mechanical ventilation for more than 3 days
  • Total ICU length of stay greater than 7 days
  • Classified as "High Risk" using a validated High-Risk Tool*
  • Expected to be discharged from hospital within the next several days

Who cannot join

  • Primary neurological diagnosis as the reason for ICU admission
  • Identified by the clinical team as being on the palliative care pathway
  • Physical activity primarily limited by the acute injury (e.g., major trauma or limb amputation)
  • Unable to mobilise independently prior to the index hospitalisation requiring ICU admission due to a long-term condition and/or disability
  • Lack of capacity or inability to provide informed consent
  • The High-Risk Tool (Walsh et al., 2022) assesses eight domains: recent hospital admissions; multimorbidity (≥4 chronic conditions); polypharmacy (≥4 regular medications); prior mental health disorder; substance misuse history; current antidepressant or antipsychotic therapy; need for assistance with activities of daily living (ADLs); and living alone or fragile social circumstances. Patients meeting ≥3 domains are classified as high risk for post-ICU deterioration and readmission.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Barat Ospanov, Dr contact

b.ospanov@sms.ed.ac.uk

United Kingdom3 sites, 3 recruiting
  • The Royal Infirmary of Edinburgh

    Edinburgh, EH16 4SA

    Zoeb Jiwaji, Dr, zoeb.jiwaji@ed.ac.uk

    Barat Ospanov, Dr, b.ospanov@sms.ed.ac.uk

    Recruiting
  • Western General Hospital

    Edinburgh, EH4 2XU

    Zoeb Jiwaji, Dr, zoeb.jiwaji@ed.ac.uk

    Recruiting
  • St Johns Hospital

    Livingston, EH54 6PP

    Zoeb Jiwaji, Dr, zoeb.jiwaji@ed.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

The primary purpose of this study is to find out whether a wrist-worn activity monitor can help healthcare professionals understand how people recover after they leave the intensive care unit (ICU), where they were cared for when they were most unwell. By tracking recovery at home, the device may help identify problems early so that the right support can be provided. The study involves adults who are discharged from the ICU in three hospitals in Edinburgh.

The main questions it aims to answer are:

Read more
  • Can movement data from a wearable device give useful information about how people feel and function after they return home following ICU and then hospital discharge?
  • Do changes in activity levels relate to changes in symptoms like pain, anxiety or behavioural measures like daily functioning, sleep and cognition? There is no comparison group in this study.

Participants will:

  • Wear a wrist-worn activity monitor
  • Answer a short set of health-related questionnaires
Read the detailed description

Many people who survive a critical illness continue to face physical, emotional, and social challenges for a prolonged period afterwards. The Critical Care Recovery Service (CCRS) supports recovery across three acute hospitals in NHS Lothian, providing coordinated physical and psychological rehabilitation for ICU survivors. Within this diverse group, rehabilitation needs are graded as low or high risk using a validated screening checklist to identify patients with complex health and social care needs.

This study is designed to collect patient reported outcome data and movement data from the dominant wrist using an accelerometer among CCRS patients. Adult patients identified as being at high risk of complex rehabilitation needs are subjected for voluntary enrolment at hospital discharge. In addition to the routine CCRS follow ups, participants in our study complete a structured telephone assessment to evaluate their health related quality of life, physical capabilities, and cognitive function over the two months following discharge, complemented by continuous wrist worn accelerometry for the entire study period.

This study will provide early evidence on the feasibility and value of integrating continuous wearable monitoring with repeated patient-reported assessments during the early post-ICU period. By linking real-world activity patterns with key domains of recovery, the findings will help identify meaningful digital indicators of deterioration or unmet rehabilitation needs.

Keywords
Critical Illness, Post-Intensive Care Syndrome, Rehabilitation, Activities of Daily Living, Cognitive Dysfunction, Patient Reported Outcome Measures, Wearable Electronic Devices, Accelerometry, Physical Function, Quality of Life, Mobility, Self-Care, Pain, Anxiety
Medical subject headings
postintensive care syndrome, Critical Illness, Cognitive Dysfunction, Pain, Anxiety Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of wearable data collection

    The proportion of enrolled post-ICU patients achieving successful data collection.

    Successful data collection is defined as:

    • 16 hours of wear time within a 24-hour period and
    • 5 valid days per week for ≥ 3 of the 4 weeks during the two-month monitoring period.

    Measured: 2 months after hospital discharge

Secondary outcomes (7)
  1. Telephone Questionnaire Completion Rate

    The proportion of included post-ICU patients who successfully complete the battery of follow-up assessments, including the EQ-5D-5L, PSQI, T-MoCA, and PROMIS PF-10a questionnaires at the following time-frames: Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

    Measured: 2 months after hospital discharge

  2. Unplanned hospital readmission rate

    The proportion of participants experiencing at least one unplanned hospital readmission following the index discharge.

    Measured: 2 months after hospital discharge.

  3. All-cause mortality

    The proportion of participants who die from any cause following index hospital discharge.

    Measured: 2 months after hospital discharge.

  4. Health-Related Quality of Life (HRQoL)

    Assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. This includes five domain scores (Mobility, Self-care, Usual activities, Pain/Discomfort, Anxiety/Depression) ranging from 1 (no problems) to 5 (extreme problems), and the EQ Visual Analogue Scale (EQ-VAS) ranging from 0 (worst imaginable health) to 100 (best imaginable health).

    Measured: Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

  5. Sleep Quality

    Assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI yields a global score ranging from 0 to 21, where lower scores denote superior sleep quality and a score > 5 indicates significant sleep disturbance.

    Measured: Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

  6. Cognitive Function

    Assessed using the Telephone Montreal Cognitive Assessment (T-MoCA). Total scores range from 0 to 22, with higher scores indicating better cognitive performance.

    Measured: Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

  7. Physical Function

    Assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function short form (PF-10a). The PF-10a is scored by summing raw scores from 10 items (rated 1-5), which are converted into a standardized T-score using conversion tables, where higher scores indicate better physical function.

    Measured: Baseline (Day 0 ± 5), 2 weeks (Day 14 ± 3), 1 month (Day 28 ± 3), and 2 months (Day 56 ± 3) post-hospital discharge.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2026
  2. Study start30 Mar 2026
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07466446
Sponsor's protocol ID
AC25224
Other IDs
15096009
Acronym
PICASSO
Status last verified
Aug 2026
First submitted
26 Feb 2026
Last updated
26 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Public Health Scotland, Scottish Intensive Care Society Audit Group, 2024. Audit of Critical Care in Scotland 2024: Reporting on 2023. Public Health Scotland, Edinburgh

  • Walsh TS, Pauley E, Donaghy E, Thompson J, Barclay L, Parker RA, Weir C, Marple J. Does a screening checklist for complex health and social care needs have potential clinical usefulness for predicting unplanned hospital readmissions in intensive care survivors: development and prospective cohort study. BMJ Open. 2022 Mar 23;12(3):e056524. doi: 10.1136/bmjopen-2021-056524.

    PubMed 35321894
  • Tsanas A. Investigating Wrist-Based Acceleration Summary Measures across Different Sample Rates towards 24-Hour Physical Activity and Sleep Profile Assessment. Sensors (Basel). 2022 Aug 17;22(16):6152. doi: 10.3390/s22166152.

    PubMed 36015910
  • National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2025. Recovery Beyond Survival: A review of the quality of rehabilitation care provided to patients following an admission to an intensive care unit. National Confidential Enquiry into Patient Outcome and Death, London.

Questions about this trial

What is this clinical trial studying?

An observational study of Post Intensive Care Syndrome (PICS), run by University of Edinburgh at 3 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zoeb Jiwaji, Dr (0044 (0)131 242 1186, zoeb.jiwaji@ed.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of wearable data collection (time frame: 2 months after hospital discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07466446, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in